Preventing Cross-Contamination during Lyophilization: GMP and Occupational Cleaning Requirements for Nonproduct and Indirect Product-Contact Parts

References

1. 1.↵
   1. Denk R.,
   2. Flueckinger A.,
   3. Kisaka H.,
   4. Maeck R.,
   5. Restetzki L.,
   6. Schreiner A.,
   7. Schulze R.

   Isolator Surfaces and Contamination Risk to Person-nel. PDA Letter [Online] 2017. https://www.pda.org/pda-letter-portal/archives/full-article/isolator-surfaces-and-contamination-risks-to-personnel (ac-cessed Nov 6, 2017).
2. 2.
   1. Denk R.,
   2. Pernau M.,
   3. Maeck R.,
   4. Zimmermann H. F.,
   5. Schönberger G.,
   6. Flückiger A.,
   7. Rückert M.,
   8. Kovats D.,
   9. Redmer J.

   Joint Assessment of Occupational Safety and GMP Aspects. Pharm. Ind. (Engl. Transl.) 2017, 79 (4), 492–498.
3. 3.↵
   European Medicines Agency. Guideline on Setting Health-Based Exposure Limits for Use in Risk Identification in the Manufacture of Different Medicinal Products in Shared Facilities: EMA/CHMP/CVMP/SWP/169430/2012 [Online]; EMA: London, 2012 (accessed Nov 20, 2014).
4. 4.↵
   ISPE/D/A/CH Affiliate Containment Manual (Engl. Transl.) [Online]; ISPE/D/A/CH Working Group: Offenbach/Main, Germany, 2016; www.ispe.org (accessed March 31, 2017).